F.P. Clinical Pharma has received the authorization from Argentinian MoH - A.N.M.A.T., for the execution of clinical studies in the area of Pharmacokinetics, Phase 1, Bioavailability and Bioequivalence at its Clinical - Pharmacokinetic Research Unit.
Argentinian MoH [I.N.A.M.E.; A.N.M.A.T.] has inspected and authorized the Bioanalytic Laboratories that work for F.P. Clinical Pharma for the development and validation of bioanalytical methods for analite/s quantification.
Authorized by Chile MoH – I.S.P.; as a Center for conducting Bioequivalence Studies with recognition in that country.
Therefore; FP Clinical Pharma’s studies are recognized by the Health Authority of Chile and are accepted to support medicinal products registration.
The authorization is valid for 3 years.
Santiago, Chile, September 5, 2011:-The National Agency of Drugs, Institute of Public Health of Chile through Exempt Resolution #1660 recognized for F.P. Clinical Pharma SRL as a CENTER OF BIOEQUIVALENCE STUDIES for the conduction of clinical, bioanalysis (analysis of drugs in biological fluids) and statistics (statistical analysis/ pharmacokinetics) of studies in bioequivalence.